Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Erin Tomiyama

Optometrist Houston, TX Doctor of Optometry

NPI 1720518418 CMS profile 3886633

4401 Martin Luther Kings Blvd, Houston, TX 77204

Open in the dashboard

General payments

$5,123

84 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$99,379 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Erin Tomiyama of Houston, TX is reported in the CMS Open Payments database as having received $5,123 across 84 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $99,379 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,732 28
2024 General $1,316 18
2023 General $931 18
2022 General $405 5
2021 General $409 9
2019 General $329 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Erin Tomiyama
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Erin Tomiyama were reported at $1,732. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Erin Tomiyama Optometrist median Middle half National median
2019 $329 $159 $67–$371 $163
2020 $0 $72 $29–$165 $114
2021 $409 $125 $46–$292 $132
2022 $405 $162 $66–$374 $149
2023 $931 $177 $72–$406 $160
2024 $1,316 $188 $77–$427 $164
2025 $1,732 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CooperVision Inc. $1,246 27 payments
  2. Glaukos Corporation $1,025 7 payments
  3. Johnson & Johnson Vision Care, Inc. $501 12 payments
  4. Visioneering Technologies, Inc. $492 3 payments
  5. Alcon Vision LLC $459 10 payments
  6. Tarsus Pharmaceuticals, Inc. $411 7 payments
  7. AbbVie, Inc. $263 1 payment
  8. Bausch & Lomb Americas Inc. $185 2 payments
  9. Carl Zeiss Meditec USA, Inc. $159 6 payments
  10. Bausch & Lomb, a division of Bausch Health US, LLC $120 3 payments
  11. Other $263 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,335 55 payments
  2. Consulting Fee $2,013 20 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $425 8 payments
  4. Honoraria $350 1 payment
Products named General payments · program years 2019–2025
  1. Acuvue $501 12 payments
  2. KXL System $500 1 payment
  3. Clariti Contact Lens $461 15 payments
  4. AIR OPTIX $425 8 payments
  5. CE-marked KXLA system $263 3 payments
  6. MiSight Contact Lens $260 4 payments
  7. VYZULTA $247 2 payments
  8. KXL system (not refurbished) $223 2 payments
  9. MyDay Contact Lens $191 3 payments
  10. CIRRUS HD-OCT $159 6 payments
  11. Other $1,089 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

84 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record